DrugPatentWatch Database Preview
Details for Patent: 8,802,624
Email this page to a colleague
Which drugs does patent 8,802,624 protect, and when does it expire?
Patent 8,802,624 protects NOCDURNA and is included in one NDA.
This patent has forty-two patent family members in twenty-eight countries.
Summary for Patent: 8,802,624
| Title: | Methods of treatment using orodispersible desmopressin pharmaceutical formulations |
| Abstract: | Described herein are methods of treating diseases or conditions such as incontinence, primary nocturnal enuresis (PNE), nocturia, and central diabetes insipidus, by administering desmopressin acetate in an orodispersiblc solid dosage form that disintegrates in the mouth within 10 seconds and includes an amount of desmopressin acetate, measured as the free base, of from 10 to 600 .mu.g. |
| Inventor(s): | Nilsson; Anders (Lund, SE), Lindner; Hans (Leichlingen, DE), Wittendorff; Jorgen (Hvidovre, DK) |
| Assignee: | Ferring B.V. (Hoofddorp, NL) |
| Application Number: | 13/110,619 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,802,624 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Dosage form; |
Drugs Protected by US Patent 8,802,624
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ferring Pharms Inc | NOCDURNA | desmopressin acetate | TABLET;SUBLINGUAL | 022517-001 | Jun 21, 2018 | RX | Yes | No | ⤷ Free Forever Trial | ⤷ Free Forever Trial | TREATMENT OF NOCTURIA DUE TO NOCTURNAL POLYURIA IN ADULTS | ⤷ Free Forever Trial | ||||
| Ferring Pharms Inc | NOCDURNA | desmopressin acetate | TABLET;SUBLINGUAL | 022517-002 | Jun 21, 2018 | RX | Yes | Yes | ⤷ Free Forever Trial | ⤷ Free Forever Trial | TREATMENT OF NOCTURIA DUE TO NOCTURNAL POLYURIA IN ADULTS | ⤷ Free Forever Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 8,802,624
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| United Kingdom | 0210397.6 | May 7, 2002 |
| PCT/IB02/04036 | Sep 20, 2002 | |
International Family Members for US Patent 8,802,624
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 039092 | ⤷ Free Forever Trial | |||
| Argentina | 039794 | ⤷ Free Forever Trial | |||
| Argentina | 107948 | ⤷ Free Forever Trial | |||
| Austria | 333886 | ⤷ Free Forever Trial | |||
| Australia | 2002337419 | ⤷ Free Forever Trial | |||
| Australia | 2003233118 | ⤷ Free Forever Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
